The DOI matches its Crossref record; 106 of the 106 references it cites were found in a registry or an index.
Tuning inflammation and immunity by chemokine sequestration: decoys and more
Abstract
A set of chemokine receptors are structurally unable to elicit migration or conventional signalling responses after ligand engagement. These 'silent' (non-signalling) chemokine receptors regulate inflammatory and immune reactions in different ways, including by acting as decoys and scavengers. Chemokine decoy receptors recognize distinct and complementary sets of ligands and are strategically expressed in different cellular contexts. Importantly, viruses and parasites have evolved multiple strategies to elude chemokines, including the expression of decoy receptors. So, decoy receptors for chemokines represent a general strategy to tune, shape and temper innate and adaptive immunity.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“As they persist in tissues, senescent cells likely create a proinflammatory tissue environment, which is known to be protumorigenic [ 3 , 64 ].”
From Senescence-Associated Secretory Phenotypes Reveal Cell-Nonautonomous Functions of Oncogenic RAS and the p53 Tumor Suppressor (2008) · cites this paper as [64]
In the citing paper
“Actually, MCP1 and MUC5AC are responsible for inflammatory cells infiltration[37] and hypersecretion of mucus [38].”
Citations
Cites
Zlotnik, A., & Yoshie, O. (2000) · Immunity · doi:10.1016/s1074-7613(00)80165-x · Cited by 3,923
Chemokines — Chemotactic Cytokines That Mediate Inflammation
Luster, A. D. (1998) · New England Journal of Medicine · doi:10.1056/nejm199802123380706 · Cited by 3,633
The many roles of chemokines and chemokine receptors in inflammation
Charo, I. F., & Ransohoff, R. M. (2006) · New England Journal of Medicine · doi:10.1056/nejmra052723 · Cited by 2,523
Rollins, B. J. (1997) · Blood · doi:10.1182/blood.v90.3.909.909_909_928 · Cited by 2,126
The Resistance Factor toPlasmodium vivaxin Blacks
Miller, L. H., Mason, S. J., CLYDE, D. F., & McGinniss, M. H. (1976) · New England Journal of Medicine · doi:10.1056/nejm197608052950602 · Cited by 1,259
The Molecular Biology of Leukocyte Chemoattractant Receptors
Murphy, P. M. (1994) · Annual Review of Immunology · doi:10.1146/annurev.iy.12.040194.003113 · Cited by 1,197
Interleukin-1 Type II Receptor: A Decoy Target for IL-1 That Is Regulated by IL-4
Colotta, F., Re, F., Muzio, M., Bertini, R., Polentarutti, N., Sironi, M., Giri, J. G., Dower, S., Sims, J. E., & Mantovani, A. (1993) · Science · doi:10.1126/science.8332913 · Cited by 979
Self-citationAnti-Immunology: Evasion of the Host Immune System by Bacterial and Viral Pathogens
Finlay, B. B., & McFadden, G. (2006) · Cell · doi:10.1016/j.cell.2006.01.034 · Cited by 917
Chemokine receptors: multifaceted therapeutic targets
Proudfoot, A. E. I. (2002) · Nature reviews. Immunology · doi:10.1038/nri722 · Cited by 755
Transcytosis and Surface Presentation of IL-8 by Venular Endothelial Cells
Middleton, J., Neil, S. J. D., Wintle, J., Clark‐Lewis, I., Moore, H. D., Lam, C., Auer, M., Hub, E., & Rot, A. (1997) · Cell · doi:10.1016/s0092-8674(00)80422-5 · Cited by 729
Flagged first, then by citations
Research works printed but not linked: 1
- Rollins, B. J. Chemokines. Blood 90, 909–928 (1997). · DOI
Cited by
Sorted by citations
Items 201–300 of 480
Chapter 1 Isolation, Identification, and Production of Posttranslationally Modified Chemokines
Loos, T., Mortier, A., & Proost, P. (2009) · Methods in enzymology on CD-ROM/Methods in enzymology · doi:10.1016/s0076-6879(09)05401-9 · Cited by 41
Flaishon, L., Hart, G., Zelman, E., Moussion, C., Grabovsky, V., Tal, G., Feigelson, S. W., Margalit, R., Harmelin, A., Avin‐Wittenberg, T., et al. (2008) · Blood · doi:10.1182/blood-2007-12-129122 · Cited by 41
Synergy‐inducing chemokines enhance CCR2 ligand activities on monocytes
Kuscher, K., Danelon, G., Paoletti, S., Stefano, L., Schiraldi, M., Petkovic, V., Locati, M., Gerber, B. O., & Uguccioni, M. (2009) · European Journal of Immunology · doi:10.1002/eji.200838906 · Cited by 40
Self-citationChemokine Receptors in T-Cell-Mediated Diseases of the Skin
Lonsdorf, A. S., Hwang, S. T., & Enk, A. (2009) · Journal of Investigative Dermatology · doi:10.1038/jid.2009.122 · Cited by 43
Gaucher disease: Chemotactic factors and immunological cell invasion in a mouse model
Pandey, M. K., Jabre, N. A., Xu, Y.-H., Zhang, W., Setchell, K. D. R., & Grabowski, G. A. (2013) · Molecular Genetics and Metabolism · doi:10.1016/j.ymgme.2013.09.002 · Cited by 41
CCL7 Is a Negative Regulator of Cutaneous Inflammation Following Leishmania major Infection
Ford, J. W., Hughson, A. L., Lim, K., Bardina, S. V., Lu, W., Charo, I. F., Lim, J. K., & Fowell, D. J. (2019) · Frontiers in Immunology · doi:10.3389/fimmu.2018.03063 · Cited by 39
Functional roles of evolutionary conserved motifs and residues in vertebrate chemokine receptors
Nomiyama, H., & Yoshie, O. (2014) · Journal of Leukocyte Biology · doi:10.1189/jlb.2ru0614-290r · Cited by 42
Shroka, T. M., Kufareva, I., Salanga, C. L., & Handel, T. M. (2023) · Science Signaling · doi:10.1126/scisignal.abo4314 · Cited by 40
Transcription analysis of the porcine alveolar macrophage response to porcine circovirus type 2
Li, W., Liu, S., Wang, Y., Deng, F., Yan, W., YANG, K. Y., Chen, H., He, Q., Charreyre, C., & Audoneet, J.-C. (2013) · BMC Genomics · doi:10.1186/1471-2164-14-353 · Cited by 39
Neutrophil‐to‐lymphocyte ratio is an independent prognostic marker for feline mammary carcinomas
Petrucci, G. N., Lobo, L., QUEIROGA, F. L., Martins, J., Prada, J., Pires, I. C. R., & Henriques, J. J. G. P. (2021) · Veterinary and Comparative Oncology · doi:10.1111/vco.12686 · Cited by 40
Yun, C.-S., Choi, Y., Jeong, M., Lee, J.-H., & Lim, S. (2012) · Journal of Natural Medicines · doi:10.1007/s11418-012-0714-3 · Cited by 39
Delaleu, N., Madureira, A. C., Immervoll, H., & Jonsson, R. (2008) · Arthritis & Rheumatism · doi:10.1002/art.23656 · Cited by 39
Mahabaleshwar, H., Tarbashevich, K., Nowak, M., Brand, M., & Raz, E. (2012) · Development · doi:10.1242/dev.080408 · Cited by 39
Russo, R. C., Savino, B., Mirolo, M., Buracchi, C., Germano, G., Anselmo, A., Zammataro, L. A., Pasqualini, F., Mantovani, A., Locati, M., et al. (2018) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00233.2017 · Cited by 40
Self-citationRegulatory pathways in inflammation
Mantovani, A., Garlanda, C., Locati, M., Rodríguez, T. V., Gonzalvo-Feo, S., Savino, B., & Vecchi, A. (2007) · Autoimmunity Reviews · doi:10.1016/j.autrev.2007.03.002 · Cited by 40
Self-citationMarchetti, L., Francisco, D. M. F., Soldati, S. G., Jahromi, N. H., Barcos, S., Gruber, I., Pareja, J. R., Thiriot, A., von Andrian, U. H., Deutsch, U., et al. (2021) · European Journal of Immunology · doi:10.1002/eji.202149238 · Cited by 38
Pandey, M. K. (2023) · Biomedicines · doi:10.3390/biomedicines11041067 · Cited by 40
Mycobacteria exploit nitric oxide‐induced transformation of macrophages into permissive giant cells
Gharun, K., Senges, J., Seidl, M., Lößlein, A. K., Kolter, J., Lohrmann, F., Fliegauf, M., Elgizouli, M., Vavra, M., Schachtrup, K., et al. (2017) · EMBO Reports · doi:10.15252/embr.201744121 · Cited by 40
Emerging Roles of the Atypical Chemokine Receptor 3 (ACKR3) in Cardiovascular Diseases
Duval, V., Alayrac, P., Silvestre, J., & Levoye, A. (2022) · Frontiers in Endocrinology · doi:10.3389/fendo.2022.906586 · Cited by 38
Mount, J. A., Karrow, N. A., Caswell, J., Boermans, H. J., & Leslie, K. E. (2009) · Europe PMC (PubMed Central) · Cited by 38
Inflammatory Reaction and Implantation: the New Entries PTX3 and D6
Garlanda, C., Maina, V., de la Torre, Y. M., Nebuloni, M., & Locati, M. (2008) · Placenta · doi:10.1016/j.placenta.2008.06.008 · Cited by 38
Self-citationChemokines as a Conductor of Bone Marrow Microenvironment in Chronic Myeloid Leukemia
Mukaida, N., Tanabe, Y., & Baba, T. (2017) · International Journal of Molecular Sciences · doi:10.3390/ijms18081824 · Cited by 38
ACKR2: An Atypical Chemokine Receptor Regulating Lymphatic Biology
Bonavita, O., Poeta, V. M., Setten, E., Massara, M., & Bonecchi, R. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00691 · Cited by 37
Self-citationRegulation of hematopoiesis by the chemokine system
Bonavita, O., Poeta, V. M., Massara, M., Mantovani, A., & Bonecchi, R. (2018) · Cytokine · doi:10.1016/j.cyto.2018.01.021 · Cited by 36
Self-citationChemokines sound the alarmin: The role of atypical chemokine in inflammation and cancer
Borroni, E. M., Savino, B., Bonecchi, R., & Locati, M. (2018) · Seminars in Immunology · doi:10.1016/j.smim.2018.10.005 · Cited by 36
Self-citationDobrzanski, M. J., Rewers‐Felkins, K., Quinlin, I. S., Samad, K. A., Phillips, C. A., Robinson, W., Dobrzanski, D. J., & Wright, S. E. (2009) · Clinical Immunology · doi:10.1016/j.clim.2009.08.007 · Cited by 37
Dermokine inhibits ELR+CXC chemokine expression and delays early skin wound healing
Hasegawa, M., Higashi, K., Matsushita, T., Hamaguchi, Y., Saito, K., Fujimoto, M., & Takehara, K. (2013) · Journal of Dermatological Science · doi:10.1016/j.jdermsci.2013.01.007 · Cited by 36
Savino, B., Castor, M. G. M. E., Caronni, N., Sarukhan, A., Anselmo, A., Buracchi, C., Benvenuti, F., Pinho, V., Teixeira, M. M., Mantovani, A., et al. (2012) · Blood · doi:10.1182/blood-2011-10-388082 · Cited by 36
Self-citationComplementary methods provide evidence for the expression of CXCR 7 on human B cells
Humpert, M., Tzouros, M., Thelen, S., Bignon, A., Levoye, A., Arenzana‐Seisdedos, F., Balabanian, K., Bachelerie, F., Langen, H., & Thelen, M. (2012) · PROTEOMICS · doi:10.1002/pmic.201100581 · Cited by 35
Wandering pathways in the regulation of innate immunity and inflammation
Mantovani, A. (2017) · Journal of Autoimmunity · doi:10.1016/j.jaut.2017.10.007 · Cited by 34
Self-citationWoodcock, T. M., Frugier, T., Nguyen, T. T., Semple, B. D., Bye, N., Massara, M., Savino, B., Besio, R., Sobacchi, C., Locati, M., et al. (2017) · PLoS ONE · doi:10.1371/journal.pone.0188305 · Cited by 34
Self-citationTargeting chemokine pathways in esophageal adenocarcinoma
Shrivastava, M. S., Hussain, Z., Giricz, O., Shenoy, N. K., Polineni, R. D., Maitra, A., & Verma, A. K. (2014) · Cell Cycle · doi:10.4161/15384101.2014.968426 · Cited by 34
Pashover‐Schallinger, E., Aswad, M., Schif‐Zuck, S., Shapiro, H., Singer, P., & Ariel, A. (2012) · The FASEB Journal · doi:10.1096/fj.11-194894 · Cited by 34
Aswad, M., Assi, S., Schif‐Zuck, S., & Ariel, A. (2017) · The Journal of Immunology · doi:10.4049/jimmunol.1502542 · Cited by 33
Chiara, M., Gagliostro, V., Bosisio, D., Prete, A. D., Tiberio, L., Thelen, M., & Sozzani, S. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.01233 · Cited by 33
Shabgah, A. G., Jadidi‐Niaragh, F., Mohammadi, H., Ebrahimzadeh, F., Oveisee, M., Jahanara, A., & Navashenaq, J. G. (2022) · Frontiers in Immunology · doi:10.3389/fimmu.2022.861931 · Cited by 33
Neutralizing endogenous chemokines with small molecules
Galzi, J., Hachet‐Haas, M., Bonnet, D., Daubeuf, F., Lecat, S., Hibert, M., Haiech, J., & Frossard, N. (2010) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2009.12.003 · Cited by 33
Sanchez, J., Huma, Z. E., Lane, J. R., Liu, X., Bridgford, J. L., Payne, R. J., Canals, M., & Stone, M. J. (2018) · Journal of Biological Chemistry · doi:10.1074/jbc.ra118.006535 · Cited by 33
Homeostatic chemokines as putative therapeutic targets in idiopathic pulmonary fibrosis
Russo, R. C., Quesniaux, V. F. J., & Ryffel, B. (2023) · Trends in Immunology · doi:10.1016/j.it.2023.10.003 · Cited by 32
D6: the ‘crowd controller’ at the immune gateway
Lee, K. M., Nibbs, R. J. B., & Graham, G. J. (2012) · Trends in Immunology · doi:10.1016/j.it.2012.08.001 · Cited by 32
Stress induced premature senescence: a new culprit in ovarian tumorigenesis?
Raghuram, G. V., & Mishra, P. K. (2014) · Europe PMC (PubMed Central) · Cited by 32
Lerrer, S., Liubomirski, Y., Bott, A., Abnaof, K., Oren, N., Yousaf, A., Körner, C., Meshel, T., Wiemann, S., & Ben‐Baruch, A. (2017) · Frontiers in Immunology · doi:10.3389/fimmu.2017.00479 · Cited by 33
Cheng, Q. J., Behzadi, F., Sen, S., Ohta, S., Spreafico, R., Teles, R. M. B., Modlin, R. L., & Hoffmann, A. (2019) · Scientific Reports · doi:10.1038/s41598-019-40503-y · Cited by 31
Neutrophil membrane-based nanotherapeutics: Propitious paradigm shift in the management of cancer
Phatale, V., Famta, P., Srinivasarao, D. A., Vambhurkar, G. B., Jain, N., Pandey, G., Kolipaka, T., Khairnar, P., Shah, S., Singh, S. B., et al. (2023) · Life Sciences · doi:10.1016/j.lfs.2023.122021 · Cited by 31
Bidirectional role of neutrophils in tumor development
Luyang, H., Zeng, F., Yan, L., Qian, H., Zhou, Y., & Xu, J. (2025) · Molecular Cancer · doi:10.1186/s12943-025-02228-7 · Cited by 34
vCCL2/vMIP-II, the viral master KEYmokine
Szpakowska, M., & Chevigné, A. (2015) · Journal of Leukocyte Biology · doi:10.1189/jlb.2mr0815-383r · Cited by 31
Tersigni, C., Vatish, M., D’Ippolito, S., Scambia, G., & Simone, N. D. (2020) · Molecular Human Reproduction · doi:10.1093/molehr/gaz067 · Cited by 31
Choi, J., Choi, B. K., Kim, J. S., Lee, J.-W., Park, H. A., Ryu, H. W., Lee, S. U., Hwang, K. W., Yun, W.-K., Kim, H.-C., et al. (2016) · PLOS ONE · doi:10.1371/journal.pone.0167098 · Cited by 30
Russo, R. C., & Ryffel, B. (2024) · Cells · doi:10.3390/cells13242058 · Cited by 35
Ubags, N. D. J., Trompette, A., Pernot, J., Nibbering, B., Wong, N. C., Pattaroni, C., Rapin, A., Nicod, L. P., Harris, N. L., & Marsland, B. J. (2020) · Journal of Allergy and Clinical Immunology · doi:10.1016/j.jaci.2020.06.030 · Cited by 30
The Breast Cancer Protooncogenes HER2, BRCA1 and BRCA2 and Their Regulation by the iNOS/NOS2 Axis
Lin, K., Baritaki, S., Vivarelli, S., Falzone, L., Scalisi, A., Libra, M., & Bonavida, B. (2022) · Antioxidants · doi:10.3390/antiox11061195 · Cited by 37
Chemokine Binding Proteins Encoded by Pathogens
Alcamı́, A., & Saraiva, M. (2009) · Advances in experimental medicine and biology · doi:10.1007/978-1-4419-1601-3_13 · Cited by 33
DARC (Duffy) and BCAM (Lutheran) reduced expression in thyroid cancer
Latini, F. R. M., Bastos, A. U., Arnoni, C. P., Muniz, J. G., Person, R. D. M., Baleotti, W., Barreto, J. A., Castilho, L. M., & Cerutti, J. M. (2012) · Blood Cells Molecules and Diseases · doi:10.1016/j.bcmd.2012.10.009 · Cited by 30
Maeda, S., Kuboki, S., Nojima, H., Shimizu, H., Yoshitomi, H., Furukawa, K., Miyazaki, M., & Ohtsuka, M. (2017) · Cytokine · doi:10.1016/j.cyto.2017.02.007 · Cited by 30
Bideak, A., Blaut, A., Hoppe, J. M., Müller, M. B., Federico, G., Eltrich, N., Gröne, H., Locati, M., & Vielhauer, V. (2018) · Kidney International · doi:10.1016/j.kint.2017.11.013 · Cited by 30
Self-citationThe N-terminal ectodomain of Ninjurin1 liberated by MMP9 has chemotactic activity
Ahn, B. J., Le, H., Shin, M. W., Bae, S., Lee, E. J., Wee, H.-J., Cha, J., Park, J., Lee, H. S., Lee, H., et al. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.10.099 · Cited by 29
Impact of CXCL1 overexpression on growth and invasion of prostate cancer cell
Benelli, R., Stigliani, S., Minghelli, S., Carlone, S., & Ferrari, N. (2013) · The Prostate · doi:10.1002/pros.22640 · Cited by 30
Cell-Autonomous Regulation of Neutrophil Migration by the D6 Chemokine Decoy Receptor
Rot, A., McKimmie, C. S., Burt, C. L., Pallas, K. J., Jamieson, T. J., Pruenster, M., Horuk, R., Nibbs, R. J. B., & Graham, G. J. (2013) · The Journal of Immunology · doi:10.4049/jimmunol.1201429 · Cited by 28
Fossati, M., Buzzonetti, A., Monego, G., Catzola, V., Scambia, G., Fattorossi, A., & Battaglia, A. (2015) · Gynecologic Oncology · doi:10.1016/j.ygyno.2015.06.003 · Cited by 28
The Role of Atypical Chemokine Receptors in Neuroinflammation and Neurodegenerative Disorders
Lindsay, H. G., Hendrix, C. J., Murcia, J. D. G., Haynie, C., & Weber, K. S. (2023) · International Journal of Molecular Sciences · doi:10.3390/ijms242216493 · Cited by 29
Serum proteomics links suppression of tumor immunity to ancestry and lethal prostate cancer
Minas, T. Z., Candia, J., Dorsey, T. H., Baker, F. S., Tang, W., Kiely, M. L., Smith, C. J., Zhang, A. L., Jordan, S. V., Obadi, O. M., et al. (2022) · Nature Communications · doi:10.1038/s41467-022-29235-2 · Cited by 27
Immune cell–camouflaged surface-engineered nanotherapeutics for cancer management
Jain, N., Shahrukh, S., Famta, P., Shah, S., Vambhurkar, G. B., Khatri, D. K., Singh, S. B., & Srivastava, S. (2022) · Acta Biomaterialia · doi:10.1016/j.actbio.2022.11.001 · Cited by 29
Kiyasu, Y., Kawada, K., Hirai, H., Ogawa, R., Hanada, K., Masui, H., Nishikawa, G., Yamamoto, T. S., Mizuno, R., Itatani, Y., et al. (2020) · Cancer Letters · doi:10.1016/j.canlet.2020.05.028 · Cited by 26
Arora, S., Khan, S. F., Zaki, A., Tabassum, G., Mohsin, M., Bhutto, H. N., Ahmad, T., Fatma, T., & Syed, M. A. (2022) · Seminars in Cancer Biology · doi:10.1016/j.semcancer.2022.03.002 · Cited by 26
Houttuynia cordata polysaccharides alleviate ulcerative colitis by restoring intestinal homeostasis
Cen, L., Yi, T., Hao, Y., Chenchen, S. H. I., Shi, X., Lu, Y., Chen, D., & Zhu, H. (2022) · Chinese Journal of Natural Medicines · doi:10.1016/s1875-5364(22)60220-6 · Cited by 27
Receptor oligomerization: A pivotal mechanism for regulating chemokine function
Martínez‐Muñoz, L., Lucas, P., Holgado, B., Barroso, R., Vega, B., Rodrı́guez-Frade, J. M., & Mellado, M. (2011) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2011.05.002 · Cited by 25
Takatsuka, S., Sekiguchi, A., Tokunaga, M., Fujimoto, A., & Chiba, J. (2010) · Journal of Pharmacological and Toxicological Methods · doi:10.1016/j.vascn.2010.12.003 · Cited by 26
CCX-CKR Expression in Colorectal Cancer and Patient Survival
Zhu, Y., Tang, W., Liu, Y., Wang, G., Liang, Z., & Cui, L. (2014) · The International Journal of Biological Markers · doi:10.5301/jbm.5000057 · Cited by 25
Tsai, Y.-C., Jeng, C., Hsiao, S.-H., Chang, H., Liu, J. J., Chang, C. C., Lin, C.-M., Chia, M., & Pang, V. F. (2010) · Veterinary Research · doi:10.1051/vetres/2010032 · Cited by 25
Feeding sentinels: Logics of care and biosecurity in farms and labs
Keck, F. (2015) · BioSocieties · doi:10.1057/biosoc.2015.6 · Cited by 25
Wiederholt, T., von Westernhagen, M., Zaldivar, M. M., Berres, M., Schmitz, P., Hellerbrand, C., Müller, T., Berg, T., Trautwein, C., & Wasmuth, H. E. (2008) · Human Immunology · doi:10.1016/j.humimm.2008.08.275 · Cited by 25
A conceptual time window‐based model for the early stratification of trauma patients
Lamparello, A. J., Namas, R. A., Constantine, G. M., McKinley, T. O., Elster, E. A., Yoram Vodovotz, B., & Billiar, T. R. (2019) · Journal of Internal Medicine · doi:10.1111/joim.12874 · Cited by 26
Jain, P. A., Shanthamurthy, C. D., Ben‐Arye, S. L., Woods, R. J., Kikkeri, R. V., & Padler‐Karavani, V. (2021) · Chemical Science · doi:10.1039/d0sc05862a · Cited by 24
Rhee, J., Kuznetsov, A., McKay, T. B., Lyons, M., Houstis, N. E., Mekonnen, J., Ethridge, B. R., Ibala, R., Hahm, E. Y., Gitlin, J., et al. (2021) · Frontiers in Aging Neuroscience · doi:10.3389/fnagi.2021.699763 · Cited by 24
Redundancy and robustness versus division of labour and specialization in innate immunity
Mantovani, A. (2017) · Seminars in Immunology · doi:10.1016/j.smim.2017.12.006 · Cited by 24
Self-citationPituitary Adenoma and the Chemokine Network: A Systemic View
Grizzi, F., Borroni, E. M., Vacchini, A., Qehajaj, D., Liguori, M., Štifter, S., Chiriva‐Internati, M., & Ieva, A. D. (2015) · Frontiers in Endocrinology · doi:10.3389/fendo.2015.00141 · Cited by 23
Michaud, D. S., Houseman, E. A., Marsit, C. J., Nelson, H. H., Wiencke, J. K., & Kelsey, K. T. (2015) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-15-0681 · Cited by 23
Xu, M., Wang, Y., Li, W.-Q., Huang, C., Li, J., Xie, W., Zeng, H., Tao, L., & Li, X. (2020) · Genes & Diseases · doi:10.1016/j.gendis.2020.08.009 · Cited by 22
Li, N., Wang, Y., Xu, H., Wang, H., Gao, Y., & Zhang, Y. (2021) · Journal of Oncology · doi:10.1155/2021/5584406 · Cited by 22
Sozio, F., Schioppa, T., Laffranchi, M., Salvi, V., Tamassia, N., Bianchetto-Aguilera, F. M., Tiberio, L., Bonecchi, R., Bosisio, D., Parmentier, M., et al. (2023) · Cancer Immunology Research · doi:10.1158/2326-6066.cir-22-0951 · Cited by 22
Self-citationSweringen, H. L. V., Sakai, N., Quillin, R. C., Bailey, J., Schuster, R. M., Blanchard, J. A., Goetzman, H. S., Caldwell, C. C., Edwards, M. J., & Lentsch, A. B. (2012) · Hepatology · doi:10.1002/hep.26049 · Cited by 22
CX3CL1/fractalkine is a novel regulator of normal and malignant human B cell function
Corcione, A., Ferretti, E., & Pistoia, V. (2012) · Journal of Leukocyte Biology · doi:10.1189/jlb.0112035 · Cited by 22
Genome Diversification Mechanism of Rodent and Lagomorpha Chemokine Genes
Shibata, K., Nomiyama, H., Yoshie, O., & Tanase, S. (2013) · BioMed Research International · doi:10.1155/2013/856265 · Cited by 22
Yue, Y., Xu, W., Hu, L., Jiang, Z., & Xiong, S. (2009) · Virology · doi:10.1016/j.virol.2009.01.029 · Cited by 22
Cheng, L., Cao, Y., Liu, S., Lv, L., Zhang, J., Bao, J., Wang, G., & Xu, P. (2025) · International Journal of Surgery · doi:10.1097/js9.0000000000002668 · Cited by 27
Xiao, Z., Liu, L., Jin, Y., Pei, X., Sun, W., & Wang, M. (2021) · Nutrients · doi:10.3390/nu13010215 · Cited by 21
Wang, C., Zhang, L.-D., Sun, Z., Yuan, X., Wu, B.-H., Cen, J., Cui, L., Zhang, K., Li, C. X., Wu, J., et al. (2022) · Hepatology · doi:10.1002/hep.32436 · Cited by 19
Chemokines as Immune Mediators of Liver Diseases Related to the Metabolic Syndrome
Berres, M., Nellen, A., & Wasmuth, H. E. (2010) · Digestive Diseases · doi:10.1159/000282085 · Cited by 21
Xiao, Z., Liu, L., Jin, Y., Pei, X., Sun, W., & Wang, M. (2021) · Molecular Nutrition & Food Research · doi:10.1002/mnfr.202001213 · Cited by 21
Yu, H., Liu, P., Yang, Y., Lee, J., Wang, L., Chen, W. J., & Chiang, B. (2013) · Journal of the Formosan Medical Association · doi:10.1016/j.jfma.2012.12.007 · Cited by 20
Watanabe, M., Horimasu, Y., Iwamoto, H., Yamaguchi, K., Sakamoto, S., Masuda, T., Nakashima, T., Miyamoto, S., Ohshimo, S., Fujitaka, K., et al. (2019) · Respiration · doi:10.1159/000500576 · Cited by 20
Park, M. H., Hong, J. E., Hwang, C. J., Choi, J. S., Choi, J. S., An, Y. J., Son, D. J., & Hong, J. T. (2016) · Archives of Pharmacal Research · doi:10.1007/s12272-016-0735-7 · Cited by 19
Protein folding, misfolding and aggregation: The importance of two-electron stabilizing interactions
Cieplak, A. S. (2017) · PLoS ONE · doi:10.1371/journal.pone.0180905 · Cited by 21
Flow cytometry applications for the analysis of chemokine receptor expression and function
Anselmo, A., Mazzon, C., Borroni, E. M., Bonecchi, R., Graham, G. J., & Locati, M. (2014) · Cytometry Part A · doi:10.1002/cyto.a.22439 · Cited by 19
Self-citationCCL2 binding is CCR2 independent in primary adult human astrocytes
Fouillet, A., Mawson, J., Suliman, O., Sharrack, B., Romero, I. A., & Woodroofe, M. N. (2011) · Brain Research · doi:10.1016/j.brainres.2011.11.049 · Cited by 19
Brás, J. P., Pinto, S. F. T., Almeida, M. I., Prata, J., von Doellinger, O., Coelho, R. C., Barbosa, M. A., & Santos, S. G. (2019) · Methods in molecular biology · doi:10.1007/978-1-4939-9554-7_28 · Cited by 19
The immunological function of CXCR2 in the liver during sepsis
Liu, N., Bauer, M. W., & Press, A. T. (2022) · Journal of Inflammation · doi:10.1186/s12950-022-00321-y · Cited by 17
Influence of Chemokine N-Terminal Modification on Biased Agonism at the Chemokine Receptor CCR1
Sanchez, J., Lane, J. R., Canals, M., & Stone, M. J. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20102417 · Cited by 18
Regulatory Mechanisms of Injury and Repair after Hepatic Ischemia/Reperfusion
Lentsch, A. B. (2012) · Scientifica · doi:10.6064/2012/513192 · Cited by 18
Shao, X., Xiang, S., Fu, H., Chen, Y., Xu, A., Liu, Y., Qi, X., Cao, J., Zhu, H., Yang, B., et al. (2019) · Pharmacological Research · doi:10.1016/j.phrs.2019.104545 · Cited by 18
Metadata
- Authors
- Mantovani, A., Bonecchi, R., & Locati, M.
- Affiliations
- University of Milan (IT)
- Corresponding author
- Mantovani, Alberto
- Venue
- Nature Reviews Immunology
- Published
- 2006-12-01
- Volume
- 6
- Issue
- 12
- Pages
- 907-918
- ISSN
- 1474-1733 (ISSN-L)
- 1474-1741
- OpenAlex
- W1970170374
- Cited by
- 481
- References
- 106
- Citations by year
- 2026: 5 · 2025: 11 · 2024: 8 · 2023: 14 · 2022: 16 · 2021: 21 · 2020: 22 · 2019: 17 · 2018: 21 · 2017: 27 · 2016: 22 · 2015: 29 · 2014: 24 · 2013: 39 · 2012: 39
- FWCI
- 3.10
- Type
- journal article
- Language
- en
- Open access
- closed
- Licence
- Locations
- Nature reviews. Immunology (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Ministero della Salute
- Ministero dell'Università e della Ricerca
- Topics
- Health Sciences › Medicine › Oncology › Chemokine receptors and signaling
- Life Sciences › Immunology and Microbiology › Immunology › Immune Response and Inflammation
- Life Sciences › Immunology and Microbiology › Immunology › Inflammation biomarkers and pathways
- Keywords
- chemokine receptors, leukocyte recruitment, inflammation regulation, immunomodulation, parasite evasion, innate immunity, adaptive immunity
- MeSH terms
- Animals, Cell Movement, Immunity, Inflammation, Parasites, Protein Conformation, Viruses, Chemokines, Receptors, Chemokine, Mice
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review